Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates
The Journal of Infection in Developing Countries · 31.03.2024 · 18 (03) · 399-406
DOI: 10.3855/jidc.18877 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.03.2024. Verfasst von Asmaa B Hamady und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Microbiology and Immunology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Although fluoroquinolones are used to treat methicillin-resistant Staphylococcus aureus (MRSA)-induced infections, acquisition of antibiotic resistance by bacteria has impaired their clinical relevance. We aimed to evaluate the frequency of norA, norB, and norC efflux pump genes-mediating fluoroquinolones resistance and measure their expression levels in MRSA isolates. Methodology: 126 S. aureus isolates were collected from different clinical samples of adult hospitalized patients and identified by conventional microbiological methods. MRSA was diagnosed by cefoxitin disc diffusion method and minimum inhibitory concentration (MIC) of ciprofloxacin by broth microdilution method. The expression levels of efflux pump genes were measured by quantitative real-time polymerase chain reaction (qRT-PCR).
Results
80 (63.5%) MRSA isolates were identified and showed high level of resistance to erythromycin (80%), gentamicin (75%), clindamycin (65%) and ciprofloxacin (60 %). norA, norB and norC were detected in 75%, 35% and 55% of the MRSA isolates respectively. norC was the most commonly overexpressed gene measured by qRT-PCR, occurring in 40% of MRSA isolates, followed by norA (35%) and norB (30%). The expression of these genes was significantly higher in ciprofloxacin-resistant than quantitative real-time PCR ciprofloxacin-sensitive MRSA isolates.
Conclusions
This study showed high prevalence and overexpression of efflux pump genes among MRSA isolates which indicates the significant role of these genes in the development of multidrug resistance against antibiotics including fluoroquinolones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Microbiology and Immunology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
- Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
- Clinical Pharmacology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
- Clinical Pathology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
- Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
Zitieren
APA
Hamady, A. B., Abd El-Fadeal, N. M., Imbaby, S., Nassar, H. M., Sakr, M. G., & Marei, Y. E. (2024). Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates. The Journal of Infection in Developing Countries, 18(03), 399-406. https://doi.org/10.3855/jidc.18877
Vancouver
Hamady AB, Abd El-Fadeal NM, Imbaby S, Nassar HM, Sakr MG, Marei YE. Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates. The Journal of Infection in Developing Countries. 2024;18(03):399-406. doi:10.3855/jidc.18877
BibTeX
@article{Hamady2024,
author = {Hamady, Asmaa B and Abd El-Fadeal, Noha M and Imbaby, Samar and Nassar, Hassnaa Ma and Sakr, Mohamed Gamal and Marei, Yara E},
title = {Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
volume = {18},
number = {03},
pages = {399--406},
doi = {10.3855/jidc.18877}
}
EUVIMED